This inventor holds 1 USPTO granted patent. Top assignees: Council of Scientific and Industrial Research, Indian Veterinary Research Institute, Unichem Laboratories Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,130 
1 out of 1 
1 out of 24 Years Active: 2011
Title: Satish Mishra - Pioneer in Rabies Vaccine Development
Introduction
Satish Mishra, an innovative inventor based in Uttar Pradesh, India, has made significant contributions to the field of vaccine development. His groundbreaking work on a chimeric G protein-based rabies vaccine showcases his commitment to advancing medical science and improving public health.
Latest Patents
Satish Mishra holds a patent for the "Chimeric G protein-based rabies vaccine," which introduces a novel chimeric protein of the rabies virus. This innovative vaccine was designed to express a chimeric G protein at a high level in transgenic plants. Through meticulous research, a gene was chemically synthesized to encode this chimeric G protein, which was subsequently expressed in transgenic tobacco plants. The therapeutic efficacy of this plant-derived vaccine against rabies was examined, revealing that the chimeric G protein enriched in the plant membranes elicited a robust immune response. Moreover, mice immunized with the plant leaf-expressed G protein exhibited protective immunity when challenged with live rabies virus, indicating its potential as a commercially valuable subunit vaccine.
Career Highlights
Throughout his career, Satish Mishra has held positions at renowned organizations such as the Council of Scientific & Industrial Research and Unichem Laboratories Limited. His work at these institutions has provided him with the platform to explore his innovative ideas and execute groundbreaking research in vaccine development.
Collaborations
In addition to his personal achievements, Satish Mishra has collaborated with notable colleagues, including Rakesh Tuli and Samir Vishwanath Sawant. Their combined expertise and shared vision have contributed to the success of his groundbreaking research endeavors.
Conclusion
Satish Mishra's advancements in rabies vaccine development depict the vital role of inventors in addressing public health challenges. His patent for the chimeric G protein-based rabies vaccine exemplifies innovation in biotechnology and offers hope for effective immunization against rabies virus infection. As research continues to evolve, the contributions of dedicated inventors like Satish Mishra will undoubtedly shape the future of vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile